| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Burden of cytogenetically abnormal plasma cells in light chain amyloidosis and their prognostic relevance
|
Kim, Seon Young
|
|
2016
|
44 |
C |
p. 45-52
8 p.
|
article
|
| 2 |
Down-regulation of EZH2 expression in myelodysplastic syndromes
|
Cabrero, Monica
|
|
2016
|
44 |
C |
p. 1-7
7 p.
|
article
|
| 3 |
Editorial board and publication information
|
|
|
2016
|
44 |
C |
p. IFC-
1 p.
|
article
|
| 4 |
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells
|
Geng, Suxia
|
|
2016
|
44 |
C |
p. 17-24
8 p.
|
article
|
| 5 |
Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry
|
Magwood-Golston, Jametta S.
|
|
2016
|
44 |
C |
p. 61-64
4 p.
|
article
|
| 6 |
Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21)
|
Zhu, Hong-Hu
|
|
2016
|
44 |
C |
p. 40-44
5 p.
|
article
|
| 7 |
SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis
|
Zhu, Yang
|
|
2016
|
44 |
C |
p. 8-16
9 p.
|
article
|
| 8 |
Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era
|
Perrone, Salvatore
|
|
2016
|
44 |
C |
p. 53-60
8 p.
|
article
|
| 9 |
The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma
|
Gonsalves, Wilson I.
|
|
2016
|
44 |
C |
p. 32-39
8 p.
|
article
|
| 10 |
Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin
|
Borate, Uma
|
|
2016
|
44 |
C |
p. 25-31
7 p.
|
article
|
Journal description